Medicover Logo

Medicover

ISIN: SE0009778848 | Ticker: MCOV | LEI: 5493000E9BUOYMOW2K53
Sector: Health CareSub-Industry: Health Care Facilities
Country: Sweden

About Medicover

Company Description

Medicover is a specialised provider of diagnostic and healthcare services, focusing on markets mainly in Central and Eastern Europe and India. The company operates through two divisions – Diagnostic Services and Healthcare Services.

Healthcare Services – offers high-quality care based on an Integrated Healthcare Model and Fee-For-Service. The basis for this is a network of 32 hospitals and 129 medical centres, 64 dental clinics, 26 fertility clinics and 77 gyms. The division accounted for 51 per cent of total revenue in 2021. Largest markets are Poland, India and Romania.

Diagnostic Services - provides a broad range of laboratory testing in all major clinical pathology areas. The business is conducted through a network of 99 laboratories, 852 blood-drawing points (BDPs) and 24 clinics. The division accounted for 49 per cent of total revenue. Largest markets are Germany, Romania, Ukraine and Poland.

Year founded

1995

Headcount

32,387

Headquarters

Riddargatan 12A, 10246 Stockholm – Sweden

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 1,110,900,000.00 1,684,300,000.00 1,831,700,000.00
Noncurrent Assets N/A 821,700,000.00 1,132,700,000.00 1,496,500,000.00
Property Plant And Equipment N/A 257,900,000.00 319,300,000.00 445,000,000.00
Goodwill N/A 289,200,000.00 371,700,000.00 495,900,000.00
Intangible Assets Other Than Goodwill N/A 64,600,000.00 75,100,000.00 126,000,000.00
Investments In Associates Accounted For Using Equity Method N/A N/A 8,500,000.00 800,000.00
Investments In Associates N/A 7,600,000.00 8,500,000.00 N/A
Deferred Tax Assets N/A 12,100,000.00 11,900,000.00 15,700,000.00
Other Noncurrent Financial Assets N/A 9,900,000.00 18,800,000.00 17,500,000.00
Current Assets N/A 289,200,000.00 551,600,000.00 335,200,000.00
Inventories N/A 53,000,000.00 72,000,000.00 58,200,000.00
Other Current Financial Assets N/A 0.00 3,100,000.00 0.00
Current Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value N/A 40,100,000.00 192,900,000.00 8,700,000.00
Cash and cash equivalents 34,800,000.00 46,700,000.00 81,900,000.00 40,400,000.00
Equity And Liabilities N/A 1,110,900,000.00 1,684,300,000.00 1,831,700,000.00
Equity 359,700,000.00 483,500,000.00 562,100,000.00 510,800,000.00
Equity Attributable To Owners Of Parent N/A 448,000,000.00 517,600,000.00 474,700,000.00
Noncontrolling Interests N/A 35,500,000.00 44,500,000.00 36,100,000.00
Liabilities N/A 627,400,000.00 1,122,200,000.00 1,320,900,000.00
Noncurrent Liabilities N/A 399,100,000.00 797,200,000.00 967,300,000.00
Deferred Tax Liabilities N/A 30,000,000.00 35,300,000.00 42,000,000.00
Other Noncurrent Financial Liabilities N/A 45,900,000.00 78,300,000.00 82,400,000.00
Other Noncurrent Liabilities N/A 3,400,000.00 5,700,000.00 2,900,000.00
Longterm Borrowings N/A N/A 375,300,000.00 473,400,000.00
Current Liabilities N/A 228,300,000.00 325,000,000.00 353,600,000.00
Trade And Other Current Payables N/A 149,400,000.00 182,400,000.00 182,600,000.00
Current Tax Liabilities Current N/A 7,800,000.00 28,800,000.00 25,500,000.00
Other Current Financial Liabilities N/A 6,800,000.00 4,600,000.00 20,500,000.00
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A N/A 42,900,000.00 42,300,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 997,800,000.00 1,377,400,000.00 1,510,200,000.00
Revenue From Interest 900,000.00 1,000,000.00 2,700,000.00
Other Gains Losses 1,500,000.00 700,000.00 -3,200,000.00
Profit Loss From Operating Activities 61,300,000.00 159,400,000.00 55,500,000.00
Profit Loss Before Tax 37,300,000.00 143,800,000.00 19,800,000.00
Income Tax Expense Continuing Operations 10,000,000.00 37,200,000.00 5,800,000.00
Profit (loss) 27,300,000.00 106,600,000.00 14,000,000.00
Profit Loss Attributable To Owners Of Parent 25,800,000.00 101,800,000.00 12,100,000.00
Profit Loss Attributable To Noncontrolling Interests 1,500,000.00 4,800,000.00 1,900,000.00
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 27,300,000.00 106,600,000.00 14,000,000.00
Adjustments For Decrease Increase In Inventories N/A -22,000,000.00 -17,100,000.00 12,700,000.00
Adjustments For Unrealised Foreign Exchange Losses Gains N/A 7,000,000.00 -2,600,000.00 3,900,000.00
Adjustments For Sharebased Payments N/A 4,700,000.00 6,400,000.00 9,600,000.00
Other Adjustments For Noncash Items N/A 5,300,000.00 -1,800,000.00 2,200,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 11,000,000.00 18,300,000.00 19,100,000.00
Cash Flows From Used In Operating Activities N/A 155,100,000.00 216,700,000.00 170,200,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 12,200,000.00 87,500,000.00 229,100,000.00
Cash Advances And Loans Made To Other Parties Classified As Investing Activities N/A 200,000.00 2,800,000.00 0.00
Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities N/A 100,000.00 0.00 N/A
Interest Received Classified As Investing Activities N/A 900,000.00 900,000.00 1,700,000.00
Other Inflows Outflows Of Cash Classified As Investing Activities N/A 10,900,000.00 40,300,000.00 186,400,000.00
Cash Flows From Used In Investing Activities N/A -126,300,000.00 -333,600,000.00 -184,800,000.00
Payments From Changes In Ownership Interests In Subsidiaries N/A 1,200,000.00 1,500,000.00 7,700,000.00
Proceeds From Issuing Shares N/A 141,900,000.00 300,000.00 0.00
Payments To Acquire Or Redeem Entitys Shares N/A 0.00 300,000.00 0.00
Proceeds From Borrowings Classified As Financing Activities N/A 181,400,000.00 293,700,000.00 524,100,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 287,800,000.00 54,700,000.00 434,700,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 31,400,000.00 38,500,000.00 50,600,000.00
Dividends Paid Classified As Financing Activities N/A 0.00 10,400,000.00 17,800,000.00
Interest Paid Classified As Financing Activities N/A 15,800,000.00 19,700,000.00 32,400,000.00
Cash Flows From Used In Financing Activities N/A -13,200,000.00 164,100,000.00 -24,300,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 15,600,000.00 47,200,000.00 -38,900,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -3,700,000.00 -12,000,000.00 -2,600,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 15,600,000.00 47,200,000.00 -38,900,000.00
Cash and cash equivalents 34,800,000.00 46,700,000.00 81,900,000.00 40,400,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
13.12.23 Fredrik Rågmark Other Other SEK 29,433,500.00
06.11.23 Fredrik Stenmo Other Buy SEK 3,871,500.00
10.08.23 Peder af Jochnick Other Buy SEK 407,886.00
09.08.23 Peder af Jochnick Other Buy SEK 235,500.00
08.08.23 Peder af Jochnick Other Buy SEK 790,000.00
04.08.23 Peder af Jochnick Other Buy SEK 320.00
02.08.23 Fredrik Stenmo Other Buy SEK 6,270,800.00
13.06.23 Fredrik Rågmark Other Sell SEK 15,691,358.40
09.06.23 Staffan Ternström Other Buy SEK 242,099.00
02.06.23 Jenny Kristina Brandt Other Sell SEK 1,192,100.00

Capital markets information

ISIN

SE0009778848

LEI

5493000E9BUOYMOW2K53

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Facilities

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.